ROYAL BANK OF CANADA - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 90 filers reported holding ONCOCYTE CORP in Q1 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$1,0003,345
+467.9%
0.00%
Q1 2023$0589
-8.4%
0.00%
Q4 2022$0
-100.0%
643
-85.2%
0.00%
Q3 2022$3,000
+200.0%
4,342
+631.0%
0.00%
Q2 2022$1,000
-85.7%
594
-87.2%
0.00%
Q1 2022$7,000
-90.5%
4,632
-86.5%
0.00%
Q4 2021$74,000
+146.7%
34,217
+299.1%
0.00%
Q3 2021$30,000
-14.3%
8,574
+39.3%
0.00%
Q2 2021$35,000
-5.4%
6,156
-12.5%
0.00%
Q1 2021$37,000
+60.9%
7,038
-26.0%
0.00%
Q4 2020$23,000
+187.5%
9,516
+75.2%
0.00%
Q3 2020$8,000
-20.0%
5,431
+1.1%
0.00%
Q2 2020$10,000
-44.4%
5,371
-27.6%
0.00%
Q1 2020$18,000
+50.0%
7,414
+38.9%
0.00%
Q4 2019$12,0000.0%5,339
-2.7%
0.00%
Q3 2019$12,000
-14.3%
5,489
-2.6%
0.00%
Q2 2019$14,000
-33.3%
5,635
+5.5%
0.00%
Q1 2019$21,0005,339
+1387.2%
0.00%
Q4 2018$0
-100.0%
359
-93.3%
0.00%
Q3 2018$13,000
-7.1%
5,3860.0%0.00%
Q2 2018$14,000
+1300.0%
5,386
+1281.0%
0.00%
Q1 2018$1,000
-50.0%
390
-0.5%
0.00%
Q4 2017$2,000
-66.7%
392
-42.8%
0.00%
Q3 2017$6,000
+200.0%
685
+57.1%
0.00%
Q2 2017$2,000
-33.3%
436
-20.9%
0.00%
Q1 2017$3,000
+50.0%
551
+134.5%
0.00%
Q4 2016$2,0000.0%235
-29.9%
0.00%
Q3 2016$2,000
-33.3%
335
-62.4%
0.00%
Q2 2016$3,000
+50.0%
890
+134.8%
0.00%
Q1 2016$2,0003790.00%
Other shareholders
ONCOCYTE CORP shareholders Q1 2021
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,596,680$27,155,0004.50%
Family Management Corp 20,550$155,0000.11%
Artal Group S.A. 150,000$1,133,0000.02%
Destination Wealth Management 29,656$224,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 145,000$1,095,0000.01%
Carroll Financial Associates, Inc. 850$5,0000.00%
Advisor Group, Inc. 112$1,0000.00%
FIFTH THIRD BANCORP 210$2,0000.00%
HUNTINGTON NATIONAL BANK 10$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 2,413$18,0000.00%
View complete list of ONCOCYTE CORP shareholders